Literature DB >> 24103353

Seroepidemiology of pertussis in a cross-sectional study of an adult general population in Denmark.

P F Rønn1, T Dalby1, J Simonsen2, C S Jørgensen3, A Linneberg4, K A Krogfelt1.   

Abstract

An increase in pertussis has been observed in several countries over the last decades, especially in adult populations. The seroprevalence of pertussis was determined in a cross-sectional study of the adult population in the Copenhagen area, Denmark, conducted between 2006 and 2008. Specific IgG antibodies against pertussis toxin (PT) were measured in 3440 persons resulting in an age-standardized seroprevalence of 3.0% (95% confidence interval 1.9-4.7) using an IgG anti-PT cut-off of 75 IU/ml. By using antibody decay profiles from longitudinal data the estimated seroincidence was 143/1000 person-years. In contrast, an incidence of 0.03/1000 person-years was estimated from the official data of notified cases during the same period. Of the investigated risk factors, only age and education were significantly associated with pertussis infection. This study indicates that pertussis is highly underestimated in the adult population in Denmark, which has implications for future prevention strategies, including raising the awareness of pertussis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24103353      PMCID: PMC9151111          DOI: 10.1017/S0950268813002446

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  34 in total

1.  A randomised, double-blind, non-inferiority clinical trial on the safety and immunogenicity of a tetanus, diphtheria and monocomponent acellular pertussis (TdaP) vaccine in comparison to a tetanus and diphtheria (Td) vaccine when given as booster vaccinations to healthy adults.

Authors:  Birgit Thierry-Carstensen; Karina Jordan; Hilde Hylland Uhlving; Tine Dalby; Charlotte Sørensen; Anders Mørup Jensen; Carsten Heilmann
Journal:  Vaccine       Date:  2012-07-06       Impact factor: 3.641

2.  Antibody responses to pertussis toxin display different kinetics after clinical Bordetella pertussis infection than after vaccination with an acellular pertussis vaccine.

Authors:  Tine Dalby; Jesper Westphal Petersen; Zitta B Harboe; Karen Angeliki Krogfelt
Journal:  J Med Microbiol       Date:  2010-05-27       Impact factor: 2.472

3.  Pertussis epidemiology in Australia over the decade 1995-2005--trends by region and age group.

Authors:  Helen E Quinn; Peter B McIntyre
Journal:  Commun Dis Intell Q Rep       Date:  2007-06

4.  Problem solved: a modified enzyme-linked immunosorbent assay for detection of human antibodies to pertussis toxin eliminates false-positive results occurring at analysis of heat-treated sera.

Authors:  Tine Dalby; Maria Seier-Petersen; Max Per Kristiansen; Zitta Barrella Harboe; Karen Angeliki Krogfelt
Journal:  Diagn Microbiol Infect Dis       Date:  2009-02-26       Impact factor: 2.803

5.  Men, masculinity, and the contexts of help seeking.

Authors:  Michael E Addis; James R Mahalik
Journal:  Am Psychol       Date:  2003-01

6.  Increased risk of pertussis in patients with asthma.

Authors:  Conrad R Capili; Allison Hettinger; Natalie Rigelman-Hedberg; Lisa Fink; Thomas Boyce; Brian Lahr; Young J Juhn
Journal:  J Allergy Clin Immunol       Date:  2011-12-28       Impact factor: 10.793

7.  Overview of pertussis: focus on epidemiology, sources of infection, and long term protection after infant vaccination.

Authors:  Kathryn M Edwards
Journal:  Pediatr Infect Dis J       Date:  2005-06       Impact factor: 2.129

8.  The incidence of Bordetella pertussis infections estimated in the population from a combination of serological surveys.

Authors:  Hester E de Melker; Florens G A Versteegh; Joop F P Schellekens; Peter F M Teunis; Mirjam Kretzschmar
Journal:  J Infect       Date:  2005-12-15       Impact factor: 6.072

Review 9.  Sources of pertussis infection in young infants: a review of key evidence informing targeting of the cocoon strategy.

Authors:  K E Wiley; Y Zuo; K K Macartney; P B McIntyre
Journal:  Vaccine       Date:  2012-11-29       Impact factor: 3.641

10.  Socioeconomic risk factors for bacteraemic pneumococcal pneumonia in adults.

Authors:  J H Flory; M Joffe; N O Fishman; P H Edelstein; J P Metlay
Journal:  Epidemiol Infect       Date:  2008-10-17       Impact factor: 2.451

View more
  10 in total

Review 1.  Bordetella pertussis evolution in the (functional) genomics era.

Authors:  Thomas Belcher; Andrew Preston
Journal:  Pathog Dis       Date:  2015-08-21       Impact factor: 3.166

Review 2.  Contribution of pertussis toxin to the pathogenesis of pertussis disease.

Authors:  Nicholas H Carbonetti
Journal:  Pathog Dis       Date:  2015-09-21       Impact factor: 3.166

Review 3.  Pertussis.

Authors:  Giovanni Gabutti; Chiara Azzari; Paolo Bonanni; Rosa Prato; Alberto E Tozzi; Alessandro Zanetti; Gianvincenzo Zuccotti
Journal:  Hum Vaccin Immunother       Date:  2014-11-01       Impact factor: 3.452

4.  Decline of serologic immunity to diphtheria, tetanus and pertussis with age suggested a full life vaccination in mainland China.

Authors:  Dandan Liu; Xiaoping Cheng; Shi Wei; Lin Yuan; Changhui Chen; Kaihu Yao
Journal:  Hum Vaccin Immunother       Date:  2021-01-30       Impact factor: 3.452

5.  An evidence synthesis approach to estimating the incidence of symptomatic pertussis infection in the Netherlands, 2005-2011.

Authors:  Scott A McDonald; Peter Teunis; Nicoline van der Maas; Sabine de Greeff; Hester de Melker; Mirjam E Kretzschmar
Journal:  BMC Infect Dis       Date:  2015-12-29       Impact factor: 3.090

6.  Seroprevalence of Bordetella pertussis antibodies in adults in Hungary: results of an epidemiological cross-sectional study.

Authors:  Péter Torzsa; Raghavendra Devadiga; Monica Tafalla
Journal:  BMC Infect Dis       Date:  2017-04-04       Impact factor: 3.090

7.  Antibody Specificity Following a Recent Bordetella pertussis Infection in Adolescence Is Correlated With the Pertussis Vaccine Received in Childhood.

Authors:  René H M Raeven; Larissa van der Maas; Jeroen L A Pennings; Kurt Fuursted; Charlotte Sværke Jørgensen; Elly van Riet; Bernard Metz; Gideon F A Kersten; Tine Dalby
Journal:  Front Immunol       Date:  2019-06-17       Impact factor: 7.561

8.  Seroprevalence of Antibodies to Pertussis Toxin among Different Age Groups in Thailand after 37 Years of Universal Whole-Cell Pertussis Vaccination.

Authors:  Nasamon Wanlapakorn; Varisara Ngaovithunvong; Thanunrat Thongmee; Preeyaporn Vichaiwattana; Sompong Vongpunsawad; Yong Poovorawan
Journal:  PLoS One       Date:  2016-02-02       Impact factor: 3.240

9.  Is adding maternal vaccination to prevent whooping cough cost-effective in Australia?

Authors:  Laure-Anne Van Bellinghen; Alex Dimitroff; Michael Haberl; Xiao Li; Andrew Manton; Karen Moeremans; Nadia Demarteau
Journal:  Hum Vaccin Immunother       Date:  2018-06-22       Impact factor: 3.452

10.  Burden of Pertussis in Individuals with a Diagnosis of Asthma: A Retrospective Database Study in England.

Authors:  Amit Bhavsar; Emmanuel Aris; Lauriane Harrington; Jason C Simeone; Anna Ramond; Dimitra Lambrelli; Alberto Papi; Louis-Philippe Boulet; Kinga Meszaros; Nicolas Jamet; Yan Sergerie; Piyali Mukherjee
Journal:  J Asthma Allergy       Date:  2022-01-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.